Delivery Order SPE2DB22D1017-SPE2DB25FH0BP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,342.88 to AmerisourceBergen Drug Corp for Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. The contract was awarded on July 28, 2025, with completion targeted for July 29, 2025, and represents a firm fixed-price delivery order with no set-aside designation. Performance will occur at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $2,014.32 delivery order to AmerisourceBergen Drug Corp for Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. This firm fixed-price delivery order was competitively awarded without set-aside designation and is due for completion by August 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order, this delivery is executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,342.88 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal conjugate vaccine. The contract is structured as a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used for this competitively awarded procurement. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,007.16 to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W vaccine kits (2 vials each). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by July 24, 2025. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,326.80 to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal vaccine product. The contract, executed on November 19, 2024, with an ultimate completion date of November 20, 2024, represents a firm fixed-price delivery order with no set-aside designation. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $2,927.28 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Menveo (1 vial A-C-Y-W-135-DIP, 0.5mL), a meningococcal vaccine product. The contract represents a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $8,060.16 to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W vaccine kits (2 vials). The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with an ultimate completion date of July 30, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location. This...
- The Defense Logistics Agency awarded a $3,357.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W Kit (2 Vials), with an ultimate completion date of August 20, 2025. This non-set-aside contract represents a pediatric meningococcal vaccine delivery under the company's existing pharmaceutical supply agreements with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- The Defense Logistics Agency awarded a $5,035.80 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. This is a firm fixed-price, competitively awarded contract with performance to be completed by August 12, 2025, and fulfillment based in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a single transaction under AmerisourceBergen's existing federal contract...
- The Defense Logistics Agency awarded a delivery order valued at $7,087.92 to AmerisourceBergen Drug Corp for Menveo A-C-Y-W Kit (2 vials) on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FH0BPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,014.32 to AmerisourceBergen Drug Corp for the provision of Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. The contract is a firm fixed price delivery order with an ultimate completion date of August 20, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform delivery at its corporate office location in the same municipality. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The company's contract awards with the Defense Logistics Agency demonstrate its established capability to fulfill federal medical procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/19/25 |